115 related articles for article (PubMed ID: 12871777)
21. Overexpression of osteopontin is associated with more aggressive phenotypes in human non-small cell lung cancer.
Hu Z; Lin D; Yuan J; Xiao T; Zhang H; Sun W; Han N; Ma Y; Di X; Gao M; Ma J; Zhang J; Cheng S; Gao Y
Clin Cancer Res; 2005 Jul; 11(13):4646-52. PubMed ID: 16000556
[TBL] [Abstract][Full Text] [Related]
22. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance.
Nguyen VN; Mirejovský T; Melinová L; Mandys V
Neoplasma; 2000; 47(6):400-8. PubMed ID: 11263866
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of osteopontin, αvβ3 and Pim-1 associated with prognostically important clinicopathologic variables in non-small cell lung cancer.
Jin Y; Tong DY; Chen JN; Feng ZY; Yang JY; Shao CK; Li JP
PLoS One; 2012; 7(10):e48575. PubMed ID: 23119061
[TBL] [Abstract][Full Text] [Related]
24. Rho-associated kinase signaling is required for osteopontin-induced cell invasion through inactivating cofilin in human non-small cell lung cancer cell lines.
Kang CG; Han HJ; Lee HJ; Kim SH; Lee EO
Bioorg Med Chem Lett; 2015 May; 25(9):1956-60. PubMed ID: 25817589
[TBL] [Abstract][Full Text] [Related]
25. [Over-expression of osteopontin in non-small cell lung cancers: its clinical significance].
Hu Z; Xiao T; Lin DM; Guo SP; Zhang ZQ; Di XB; Cheng SJ; Gao YN
Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):591-5. PubMed ID: 18210878
[TBL] [Abstract][Full Text] [Related]
26. Osteopontin (OPN) may facilitate metastasis by protecting cells from macrophage NO-mediated cytotoxicity: evidence from cell lines down-regulated for OPN expression by a targeted ribozyme.
Feng B; Rollo EE; Denhardt DT
Clin Exp Metastasis; 1995 Nov; 13(6):453-62. PubMed ID: 7586803
[TBL] [Abstract][Full Text] [Related]
27. Impaired anti-tumor cytotoxicity of macrophages from osteopontin-deficient mice.
Bourassa B; Monaghan S; Rittling SR
Cell Immunol; 2004 Jan; 227(1):1-11. PubMed ID: 15051510
[TBL] [Abstract][Full Text] [Related]
28. CD44s is a crucial ATG7 downstream regulator for stem-like property, invasion, and lung metastasis of human bladder cancer (BC) cells.
Zhu J; Huang G; Hua X; Li Y; Yan H; Che X; Tian Z; Liufu H; Huang C; Li J; Xu J; Dai W; Huang H; Huang C
Oncogene; 2019 Apr; 38(17):3301-3315. PubMed ID: 30635654
[TBL] [Abstract][Full Text] [Related]
29. An Osteopontin/CD44 Axis in RhoGDI2-Mediated Metastasis Suppression.
Ahmed M; Sottnik JL; Dancik GM; Sahu D; Hansel DE; Theodorescu D; Schwartz MA
Cancer Cell; 2016 Sep; 30(3):432-443. PubMed ID: 27593345
[TBL] [Abstract][Full Text] [Related]
30. Bu Fei Decoction attenuates the tumor associated macrophage stimulated proliferation, migration, invasion and immunosuppression of non-small cell lung cancer, partially via IL-10 and PD-L1 regulation.
Pang L; Han S; Jiao Y; Jiang S; He X; Li P
Int J Oncol; 2017 Jul; 51(1):25-38. PubMed ID: 28534943
[TBL] [Abstract][Full Text] [Related]
31. Interaction between the adhesion receptor, CD44, and the oncogene product, p185HER2, promotes human ovarian tumor cell activation.
Bourguignon LY; Zhu H; Chu A; Iida N; Zhang L; Hung MC
J Biol Chem; 1997 Oct; 272(44):27913-8. PubMed ID: 9346940
[TBL] [Abstract][Full Text] [Related]
32. Stable alterations of CD44 isoform expression in prostate cancer cells decrease invasion and growth and alter ligand binding and chemosensitivity.
Yang K; Tang Y; Habermehl GK; Iczkowski KA
BMC Cancer; 2010 Jan; 10():16. PubMed ID: 20074368
[TBL] [Abstract][Full Text] [Related]
33. Expression and significance of CD44s, CD44v6, and nm23 mRNA in human cancer.
Liu YJ; Yan PS; Li J; Jia JF
World J Gastroenterol; 2005 Nov; 11(42):6601-6. PubMed ID: 16425351
[TBL] [Abstract][Full Text] [Related]
34. The CD44 standard isoform contributes to radioresistance of pancreatic cancer cells.
Tsubouchi K; Minami K; Hayashi N; Yokoyama Y; Mori S; Yamamoto H; Koizumi M
J Radiat Res; 2017 Nov; 58(6):816-826. PubMed ID: 29106581
[TBL] [Abstract][Full Text] [Related]
35. An evaluation of tumor oxygenation and gene expression in patients with early stage non-small cell lung cancers.
Le QT; Chen E; Salim A; Cao H; Kong CS; Whyte R; Donington J; Cannon W; Wakelee H; Tibshirani R; Mitchell JD; Richardson D; O'Byrne KJ; Koong AC; Giaccia AJ
Clin Cancer Res; 2006 Mar; 12(5):1507-14. PubMed ID: 16533775
[TBL] [Abstract][Full Text] [Related]
36. CD44 is functionally crucial for driving lung cancer stem cells metastasis through Wnt/β-catenin-FoxM1-Twist signaling.
Su J; Wu S; Wu H; Li L; Guo T
Mol Carcinog; 2016 Dec; 55(12):1962-1973. PubMed ID: 26621583
[TBL] [Abstract][Full Text] [Related]
37. Endostar, a modified endostatin inhibits non small cell lung cancer cell in vitro invasion through osteopontin-related mechanism.
Ni Q; Ji H; Zhao Z; Fan X; Xu C
Eur J Pharmacol; 2009 Jul; 614(1-3):1-6. PubMed ID: 19389394
[TBL] [Abstract][Full Text] [Related]
38. The prognostic value of osteopontin expression in non-small cell lung cancer: a meta-analysis.
Zhang T; Zhang DM; Zhao D; Hou XM; Liu XJ; Ling XL; Ma SC
J Mol Histol; 2014 Oct; 45(5):533-40. PubMed ID: 24816798
[TBL] [Abstract][Full Text] [Related]
39. CD44 stimulation down-regulates Fas expression and Fas-mediated apoptosis of lung cancer cells.
Yasuda M; Tanaka Y; Fujii K; Yasumoto K
Int Immunol; 2001 Oct; 13(10):1309-19. PubMed ID: 11581176
[TBL] [Abstract][Full Text] [Related]
40. Inhibitory effect of ethanol extract of Ocimum sanctum on osteopontin mediated metastasis of NCI-H460 non-small cell lung cancer cells.
Kwak TK; Sohn EJ; Kim S; Won G; Choi JU; Jeong K; Jeong M; Kwon OS; Kim SH
BMC Complement Altern Med; 2014 Oct; 14():419. PubMed ID: 25345853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
